Cas:399-10-0 2-Propen-1-one, 1- (4-fluorophenyl)-3-phenyl- manufacturer & supplier

Chemical Name:2-Propen-1-one, 1- (4-fluorophenyl)-3-phenyl-

CAS.NO:399-10-0

Synonyms:(2E)-1-(4-Fluorophenyl)-3-phenyl-2-propen-1-one;2-Propen-1-one, 1- (4-fluorophenyl)-3-phenyl-;2-Benzylidene-4′-fluoroacetophenone;(E)-1-(4-Fluorophenyl)-3-phenylprop-2-en-1-one;2-Propen-1-one, 1-(4-fluorophenyl)-3-phenyl-, (2E)-;4′-FLUOROCHALCONE;4′-Fluorochalcone;(2E)-1-(4-fluorophenyl)-3-phenylprop-2-en-1-one;4‘-Fluorochalcone;2-Benzal-4′-fluoroacetophenone;MFCD00017961

Molecular Formula:C₁₅H₁₁FO

Molecular Weight:226.246

HS Code:2914700090

Physical and Chemical Properties:

Melting point:79-80 °C

Boiling point:358.0±42.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.608

PSA:17.07000

Exact Mass:226.079391

LogP:4.23

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2E)-1-(4-Fluorophenyl)-3-phenyl-2-propen-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00017961 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(E)-1-(4-Fluorophenyl)-3-phenylprop-2-en-1-one Use and application,2-Propen-1-one, 1-(4-fluorophenyl)-3-phenyl-, (2E)- technical grade,usp/ep/jp grade.

Related News: Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 2-Propen-1-one, 1- (4-fluorophenyl)-3-phenyl- manufacturer Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. 2-Propen-1-one, 1- (4-fluorophenyl)-3-phenyl- supplier As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 2-Propen-1-one, 1- (4-fluorophenyl)-3-phenyl- vendor As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 2-Propen-1-one, 1- (4-fluorophenyl)-3-phenyl- factory Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good.